drugset / Trial / NCT01601847

Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy

NCT01601847

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The goal of this study is to identify a vitamin D supplementation strategy that best promotes the lung, immune, and overall health of black infants born preterm (28-36 weeks gestational age). This is a high risk population that seems to have unique vitamin D needs, and inappropriate supplementation may promote wheezing or allergy. The results of this study will help form nutritional recommendations for the approximately 100,000 black infants born at 30-36 weeks gestational age in the U.S. every year.

Timeline

Start
2013-01
Primary completion
2017-03-12
Completion
2017-03-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 400 iu Oral

Indications